Bioage Labs Inc Receivables Turnover Ratio (BIOA), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bioage Labs Inc   (NASDAQ: BIOA)
 

Bioage Labs Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Bioage Labs Inc 's ability to collect accounts receivable sequentially worsen to 8.09, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Bioage Labs Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 45 days, from 23 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 68 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 767, from overall ranking in the first quarter 2026 at 910.

What is Receivable Turnover Ratio?
What is Bioage Labs Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BIOA Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change 418.24 % 96.4 % - - -
Y / Y Revenue Change 1.62 % 91.04 % - - -
Receivable Turnover Ratio (TTM) 8.09 15.9 16.01 16 16.03
BIOA's Total Ranking # 767 # 910 # # #
Accounts Receivable average collection period days 45 23 23 23 23
Seq. Receivable Change 340.76 % -7.8 % 49.32 % -14.59 % 67.04 %
Seq. Revenue Change -11.58 % -9.94 % 49.85 % -14.84 % 66.23 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 69
Overall Market # 767

Receivable Turnover Ratio Statistics
High Average Low
16.01 5.68 2.23
(Dec 31 2025)   (Mar 31 2013)





BIOA Company Profile • Back to BIOA Efficiency Comparisons • Compare BIOA Receivables Turnover Ratio to its Competitors

Financial Statements
Bioage Labs Inc 's Accounts Receivable $ 3 Millions Visit BIOA's Balance sheet
Bioage Labs Inc 's Sales TTM $ 10 Millions Visit BIOA's Income Statement
Sources of BIOA's Revenues Visit BIOA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BIOA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BIOA's Growth Rates BIOA's Roa BIOA's Inventory Turnover Ratio BIOA's Dividend Comparisons
BIOA's Profitability Ratios BIOA's Roi BIOA's Asset Turnover Ratio BIOA's Dividend Growth
BIOA's Valuation Ratios BIOA's Roe BIOA's Financial Strength Ratios BIOA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Novavax inc   9.06 $ 413.796  Millions$ 45.668  Millions
Nuvation Bio Inc   9.05 $ 169.551  Millions$ 18.737  Millions
Cue Biopharma Inc   9.04 $ 37.654  Millions$ 4.165  Millions
Sunshine Biopharma Inc   9.03 $ 35.347  Millions$ 3.916  Millions
Biocryst Pharmaceuticals Inc   9.00 $ 940.613  Millions$ 104.543  Millions
Edwards Lifesciences Corporation  8.99 $ 6,512.500  Millions$ 724.750  Millions
Cannapharmarx Inc   8.86 $ 1.699  Millions$ 0.192  Millions
Grail Inc   8.85 $ 165.263  Millions$ 18.670  Millions
Guardant Health Inc   8.84 $ 1,183.105  Millions$ 133.772  Millions
Zomedica Corp   8.84 $ 35.903  Millions$ 4.063  Millions
Scientific Industries Inc   8.83 $ 5.728  Millions$ 0.649  Millions
Sanara Medtech Inc   8.76 $ 110.116  Millions$ 12.568  Millions
Pacs Group Inc   8.75 $ 5,551.038  Millions$ 634.735  Millions
Acadia Pharmaceuticals Inc   8.70 $ 1,138.643  Millions$ 130.825  Millions
Fate Therapeutics Inc   8.64 $ 6.491  Millions$ 0.751  Millions
Tactile Systems Technology Inc   8.62 $ 350.319  Millions$ 40.623  Millions
Cg Oncology Inc   8.61 $ 6.228  Millions$ 0.724  Millions
Pediatrix Medical Group Inc   8.54 $ 1,950.625  Millions$ 228.297  Millions
Sotera Health Company  8.54 $ 1,215.925  Millions$ 142.378  Millions
Volitionrx Limited  8.50 $ 2.458  Millions$ 0.289  Millions
Ensign Group Inc  8.50 $ 5,486.708  Millions$ 645.470  Millions
Tenet Healthcare Corp  8.47 $ 21,812.000  Millions$ 2,574.000  Millions
Inogen Inc   8.47 $ 354.304  Millions$ 41.817  Millions
Adapthealth Corp   8.42 $ 3,226.709  Millions$ 383.393  Millions
Axogen inc   8.42 $ 251.174  Millions$ 29.846  Millions
Becton Dickinson And Company  8.37 $ 20,840.000  Millions$ 2,489.750  Millions
Pulse Biosciences Inc   8.35 $ 1.185  Millions$ 0.142  Millions
Alpha Teknova Inc   8.33 $ 43.407  Millions$ 5.208  Millions
Rockwell Medical inc   8.31 $ 69.827  Millions$ 8.400  Millions
Inspire Medical Systems inc   8.25 $ 899.227  Millions$ 109.027  Millions

Date modified: 2026-09-10T09:28:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.